Healthtech Startups

Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.

6 investors

Relay is a group-based support program designed to help individuals address pornography and unwanted sexual behaviors through daily encouragement, accountability, and community support.

6 investors

Smart ventilation monitoring (exit)

6 investors

Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development. It operates an Organ ICU facility and works with organ procurement organizations and healthcare institutions to serve pharma, biotech, and medical device companies.

6 investors

Rex operates a chain of veterinary practices for pet owners across Germany, with locations in cities including Stuttgart, Düsseldorf, Frankfurt, Munich, Cologne, Berlin, and Hamburg.

6 investors

Rise Science develops RISE, a mobile app that tracks sleep and energy levels while providing personalized recommendations based on sleep debt and circadian rhythm science. The app is designed for consumers seeking to optimize sleep quality and daily energy to improve productivity and overall performance.

6 investors

ROOK provides a wearable health data API that enables developers and companies to integrate health and fitness data from wearable devices into their applications. The company serves fitness apps, health platforms, automotive companies, and other enterprises seeking to personalize user experiences and drive innovation through accessible wearable data.

6 investors

RubyWell connects family caregivers of homebound older adults with Medicare Advantage plans and home health agencies, offering care navigation support, training, and monthly stipends through a structured study program. Its technology helps caregivers identify early health signals and access Medicare-covered home health services to reduce avoidable hospitalizations for chronically ill patients in the US.

6 investors

Runna provides personalized running training plans for athletes of all levels, from beginners to elite competitors, covering distances from 5K to ultramarathons. The app integrates with wearables like Apple Watch and Garmin to track workouts and includes strength training, injury recovery, and coaching support.

6 investors

Rylo is a free call captioning and live transcription mobile app that provides real-time captions for phone calls, voicemails, and in-person conversations, with support for 50+ languages. It is designed for people who are Deaf, hard of hearing, or have speech disabilities, and operates as an FCC-certified captioned telephone and IP Relay service.

6 investors

Saama provides AI-based data analytics solutions and services for the life sciences industry, with a focus on accelerating clinical trials. Its offerings also extend to sectors including banking and capital markets, consumer goods, insurance, and the public sector.

6 investors

Sanity Group manufactures and distributes cannabinoid-based pharmaceutical products under the avaay Medical brand across European markets, including medical cannabis. The company operates in the medical cannabis and pharmaceutical sector, with a focus on patient access to cannabis-based therapeutics.

6 investors

Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases. The company focuses on novel therapeutic approaches for patients with rare respiratory conditions.

6 investors

Scout develops portable molecular diagnostic testing devices that deliver lab-grade accuracy in under 30 minutes for point-of-care use. The platform enables healthcare providers to test and treat patients in real-time without requiring lab infrastructure or specialized training.

6 investors

Scribe is a molecular engineering company developing CRISPR-based genetic therapies to treat cardiometabolic disease and other conditions. The company uses advanced engineering of natural CRISPR systems to create targeted genetic medicines.

6 investors

Second Nature runs a clinically-informed weight-loss programme, including a medication-supported option, that focuses on building healthier eating habits and behaviour change rather than calorie counting. It serves individuals seeking to lose weight and improve metabolic health such as blood sugar levels.

6 investors

Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure. It is a publicly listed medical device company addressing unmet needs in the management of ascites and related conditions.

6 investors

Sequence Bio discovers genetic causes of disease within Newfoundland and Labrador's founder population to develop breakthrough treatments, diagnostics, and preventions. The company focuses on translational biology and genetics research for patients globally.

6 investors

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.

6 investors

Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.

6 investors

SFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases. The company's lead program, SFA-002, is in Phase 2 development for plaque psoriasis, with additional pipeline assets targeting pancreatic cancer, liver cancer, rheumatoid arthritis, and inflammatory bowel disease.

6 investors

Sift Healthcare builds RevProtect, a predictive analytics platform that helps health systems anticipate reimbursement denials and optimize revenue cycle management before claims are submitted. The platform integrates clinical context and payer response patterns to deliver role-specific actions embedded in existing workflows.

6 investors

Siftwell is a healthcare technology company founded by former health plan operators and clinicians that applies data analytics and operational expertise to improve managed care organization (MCO) operations and member outcomes.

6 investors

SimpliFed provides a maternal health operating system delivering virtual care and support for parents during pregnancy, postpartum, and baby feeding. The platform serves healthcare providers and families seeking accessible postpartum care and lactation support regardless of geography or socioeconomic status.

6 investors